低所得国および中所得国における3つの臨床試験における患者健康アンケート (PHQ-9) の項目の変化に対する感受性
Olawale F Ayilara1, Alicia White2, Gerard Dunleavy2
1Department of Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
Journal of affective disorders
|September 6, 2025
まとめ
9項目の患者健康アンケート (PHQ-9) は,うつ病の症状の変化を効果的に追跡します. 個々の項目,特にうつ病的気分と安ヘドニアは,変化に敏感であり,PHQ-9は研究と臨床使用に価値があります.
科学分野:
- 精神科
- 心理的な測定
- 臨床心理学
背景:
- 9項目の患者健康アンケート (PHQ-9) は,うつ病の症状を評価するための標準的なツールです.
- 以前の研究では,要約スコアレベルでの感度が確認されています.
- 個々のPHQ-9項目の変化感度に関するデータは限られている.
研究 の 目的:
- 個々のPHQ-9項目が時間とともに変化する感覚を評価する.
- ランダム化制御試験の3つの異なるデータセットでこの敏感性を分析する.
- 縦断的な抑うつ研究における特定のPHQ-9項目の有用性を決定する.
主な方法:
- 3つのランダム化制御試験の縦断データによる二次分析.
- 制限と制限のない縦関数モデルの適用
- 複数の適合度指数を用いて測定モデルの適合度を評価する.
主要な成果:
- PHQ-9の項目は,すべてのデータセットで変化に対する一般的な感受性を示しました.
- 項目2 (うつ病の気分) は1つのデータセットで最も敏感で,項目1 (アネドニア) と項目2は他のデータセットで最も敏感でした.
- 項目9 (自殺傾向) は変化に対して最も敏感ではありません.
結論:
- 個々のPHQ-9項目は,うつ病の症状における個人の変化に敏感です.
- これらの発見は,研究および臨床環境における症状の変動を追跡するためのPHQ-9の適性を支持する.
- この研究は,うつ病を長期的にモニタリングするための特定のアイテムの使用を検証しています.
さらに関連する動画
関連する概念動画
01:16Clinical Trials
7.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.5K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
173
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
173
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
01:13Sensitivity, Specificity, and Predicted Value
651
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...
651
01:17Cochran's Q Test
540
Cochran's Q Test is a nonparametric statistical test used to determine if there are potential differences in the outcomes of three or more related groups on a binary (yes/no) or dichotomous outcome. It is essentially an extension of the McNemar Test, which is limited to two related samples - Cochran's Q test can handle three or more related samples, making it more versatile in scenarios where subjects are measured under multiple conditions. The test statistic follows a Chi-Square...
540
01:23Assessment of the Cardiovascular System I: Subjective Data
465
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
465